Challenges in designing a national surveillance program for inflammatory bowel disease in the United States

Millie D. Long, Susan Hutfless, Michael D. Kappelman, Hamed Khalili, Gilaad G. Kaplan, Charles N. Bernstein, Jean Frederic Colombel, Corinne Gower-Rousseau, Lisa Herrinton, Fernando Velayos, Edward V. Loftus, Geoffrey C. Nguyen, Ashwin N. Ananthakrishnan, Amnon Sonnenberg, Andrew Chan, Robert S. Sandler, Ashish Atreja, Samir A. Shah, Kenneth J. Rothman, Neal S. LeleikoRenee Bright, Paolo Boffetta, Kelly D. Myers, Bruce E. Sands

Research output: Contribution to journalReview articlepeer-review

Abstract

This review describes the history of U.S. government funding for surveillance programs in inflammatory bowel diseases (IBD), provides current estimates of the incidence and prevalence of IBD in the United States, and enumerates a number of challenges faced by current and future IBD surveillance programs. A rationale for expanding the focus of IBD surveillance beyond counts of incidence and prevalence, to provide a greater understanding of the burden of IBD, disease etiology, and pathogenesis, is provided. Lessons learned from other countries are summarized, in addition to potential resources that may be used to optimize a new form of IBD surveillance in the United States. A consensus recommendation on the goals and available resources for a new model for disease surveillance are provided. This new model should focus on "surveillance of the burden of disease," including (1) natural history of disease and (2) outcomes and complications of the disease and/or treatments.

Original languageEnglish (US)
Pages (from-to)398-415
Number of pages18
JournalInflammatory bowel diseases
Volume20
Issue number2
DOIs
StatePublished - Feb 1 2014

Keywords

  • Clinical areas
  • Epidemiology
  • Outcomes research/measurements

ASJC Scopus subject areas

  • Immunology and Allergy
  • Gastroenterology

Fingerprint Dive into the research topics of 'Challenges in designing a national surveillance program for inflammatory bowel disease in the United States'. Together they form a unique fingerprint.

Cite this